Phase I study of VRCTC-310, a purified phospholipase A2...

Anti-Cancer Drugs 1997 / 10 Vol. 8; Iss. 9

Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data

Costa, Luis A., Miles, Horacio A., Diez, Roberto A., Araujo, Carlos E., Molina, Carlos M., Cervellino, Juan C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-199710000-00003
Date:
October, 1997
File:
PDF, 493 KB
1997
Conversion to is in progress
Conversion to is failed